Reply to: Dose- and exposure-response to ketamine in depression

Biological Psychiatry

Volumn 70, Issue 4, 2011, Pages

  Murrough, James W ^a   Gallo, James M ^a   Collins, Katherine A ^a   Aan Het Rot, Marije ^b   Charney, Dennis S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE;

ANALGESIC ACTIVITY; BIPOLAR II DISORDER; CHRONIC PAIN; DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; LETTER; LOW DRUG DOSE; MAXIMUM PLASMA CONCENTRATION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT DURATION;

EID: 79960780652     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2011.02.018     Document Type: Letter

References (9)

1. P. Glue, A. Gulati, M. Le Nedelec, and S. Duffull Dose- and exposure-response to ketamine in depression Biol Psychiatry 70 2011 e9 e10
2. S.J. Mathew, J.W. Murrough, M. aan het Rot, K.A. Collins, D.L. Reich, and D.S. Charney Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: A pilot randomized, placebo-controlled continuation trial Int J Neuropsychopharmacol 13 2010 71 82
3. M. aan het Rot, K.A. Collins, J.W. Murrough, A.M. Perez, D.L. Reich, D.S. Charney, and S.J. Mathew Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression Biol Psychiatry 67 2010 139 145
4. C.A. Zarate Jr, J.B. Singh, P.J. Carlson, N.E. Brutsche, R. Ameli, and D.A. Luckenbaugh A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression Arch Gen Psychiatry 63 2006 856 864 (Pubitemid 44188478)
5. I.S. Grant, W.S. Nimmo, and J.A. Clements Pharmacokinetics and analgesic effects of intramuscular and oral ketamine Br J Anaesth 53 1981 805 810 (Pubitemid 11044337)
6. H. Ihmsen, G. Geisslinger, and J. Schuttler Stereoselective pharmacokinetics of ketamine: R()-ketamine inhibits the elimination of S(+)-ketamine Clin Pharmacol Ther 70 2001 431 438 (Pubitemid 33135322)
7. J.A. Clements, W.S. Nimmo, and I.S. Grant Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans J Pharmacol Sci 71 1982 539 542 (Pubitemid 12063731)
8. Y. Yanagihara, M. Ohtani, S. Kariya, K. Uchino, T. Hiraishi, and N. Ashizawa Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers Biopharm Drug Dispos 24 2003 37 43 (Pubitemid 36124167)
9. R.J. Schwartzman, G.M. Alexander, J.R. Grothusen, T. Paylor, E. Reichenberger, and M. Perreault Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: A double-blind placebo controlled study Pain 147 2009 107 115